Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RXRX | RCUS |
|---|---|---|
| Price | $4.78 | $24.74 |
| Change today | ▲ 16.02% | ▲ 1.23% |
| Market cap | $2.56B | $3.15B |
| Return, 3 months | +24.5% | -18.2% |
| Return, year to date | +16.9% | +3.8% |
| Return, 1 year | -13.6% | +70.9% |
| P/E (TTM) | -4.8 | -6.3 |
| P/B | 2.8 | 6.8 |
| P/E percentile vs own 5y | 49th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +39.1% | +70.3% |
| Analyst buy share | 40% | 89% |
| RSI (14) | 72 | 39 |
| 30-day volatility | 89.6% | 47.3% |
| Max drawdown, 1 year | -58.2% | -27.8% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
